PubMed

Natural progression of diabetic peripheral neuropathy in the Zenarestat study population.

Brown MJ, Bird SJ, Watling S, Kaleta H, Hayes L, Eckert S, Foyt HL; Zenarest study.

Diabetes Care. 2004 May;27(5):1153-9.PMID: 15111537 [PubMed - indexed for MEDLINE]Related articlesFree article

Value of repeated measures of nerve conduction and quantitative sensory testing in a diabetic neuropathy trial.

Bird SJ, Brown MJ, Spino C, Watling S, Foyt HL.

Muscle Nerve. 2006 Aug;34(2):214-24.PMID: 16708368 [PubMed - indexed for MEDLINE]Related articles

One-year treatment with the aldose reductase inhibitor, ponalrestat, in diabetic neuropathy.

Ziegler D, Mayer P, Rathmann W, Gries FA.

Diabetes Res Clin Pract. 1991 Oct;14(1):63-73.PMID: 1748064 [PubMed - indexed for MEDLINE]Related articles

A meta-analysis of trials on aldose reductase inhibitors in diabetic peripheral neuropathy. The Italian Study Group. The St. Vincent Declaration.

Nicolucci A, Carinci F, Cavaliere D, Scorpiglione N, Belfiglio M, Labbrozzi D, Mari E, Benedetti MM, Tognoni G, Liberati A.

Diabet Med. 1996 Dec;13(12):1017-26.PMID: 8973882 [PubMed - indexed for MEDLINE]Related articles

Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study.

Hotta N, Toyota T, Matsuoka K, Shigeta Y, Kikkawa R, Kaneko T, Takahashi A, Sugimura K, Koike Y, Ishii J, Sakamoto N; SNK-860 Diabetic Neuropathy Study Group.

Diabetes Care. 2001 Oct;24(10):1776-82. Erratum in: Diabetes Care 2002 Feb;25(2):413-4. PMID: 11574441 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term effects of ranirestat (AS-3201) on peripheral nerve function in patients with diabetic sensorimotor polyneuropathy.

Bril V, Buchanan RA.

Diabetes Care. 2006 Jan;29(1):68-72.PMID: 16373898 [PubMed - indexed for MEDLINE]Related articlesFree article

Ranirestat for the management of diabetic sensorimotor polyneuropathy.

Bril V, Hirose T, Tomioka S, Buchanan R; Ranirestat Study Group.

Diabetes Care. 2009 Jul;32(7):1256-60. Epub 2009 Apr 14.PMID: 19366965 [PubMed - indexed for MEDLINE]Related articlesFree article

Withdrawal of the aldose reductase inhibitor tolrestat in patients with diabetic neuropathy: effect on nerve function. The Tolrestat Study Group.

Santiago JV, Snksen PH, Boulton AJ, Macleod A, Beg M, Bochenek W, Graepel GJ, Gonen B.

J Diabetes Complications. 1993 Jul-Sep;7(3):170-8.PMID: 8343611 [PubMed - indexed for MEDLINE]Related articles

Correlation of vibratory quantitative sensory testing and nerve conduction studies in patients with diabetes.

Kincaid JC, Price KL, Jimenez MC, Skljarevski V.

Muscle Nerve. 2007 Dec;36(6):821-7.PMID: 17683081 [PubMed - indexed for MEDLINE]Related articles

Clinical investigation of epalrestat, an aldose reductase inhibitor, on diabetic neuropathy in Japan: multicenter study. Diabetic Neuropathy Study Group in Japan.

Hotta N, Sakamoto N, Shigeta Y, Kikkawa R, Goto Y.

J Diabetes Complications. 1996 May-Jun;10(3):168-72.PMID: 8807467 [PubMed - indexed for MEDLINE]Related articles

Reproducibility of parameters for assessment of diabetic neuropathy. The French Group for Research and Study of Diabetic Neuropathy.

Valensi P, Attali JR, Gagant S.

Diabet Med. 1993 Dec;10(10):933-9.PMID: 8306589 [PubMed - indexed for MEDLINE]Related articles

Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial.

Hotta N, Akanuma Y, Kawamori R, Matsuoka K, Oka Y, Shichiri M, Toyota T, Nakashima M, Yoshimura I, Sakamoto N, Shigeta Y.

Diabetes Care. 2006 Jul;29(7):1538-44.PMID: 16801576 [PubMed - indexed for MEDLINE]Related articlesFree article

Aldose reductase inhibition ameliorates pupillary light reflex and F-wave latency in patients with mild diabetic neuropathy.

Nakayama M, Nakamura J, Hamada Y, Chaya S, Mizubayashi R, Yasuda Y, Kamiya H, Koh N, Hotta N.

Diabetes Care. 2001 Jun;24(6):1093-8.PMID: 11375376 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of treatment with an aldose-reductase inhibitor on symptomatic carpal tunnel syndrome in type 2 diabetes.

Monge L, De Mattei M, Dani F, Sciarretta A, Carta Q.

Diabet Med. 1995 Dec;12(12):1097-101.PMID: 8750220 [PubMed - indexed for MEDLINE]Related articles

Elevated triglycerides correlate with progression of diabetic neuropathy.

Wiggin TD, Sullivan KA, Pop-Busui R, Amato A, Sima AA, Feldman EL.

Diabetes. 2009 Jul;58(7):1634-40. Epub 2009 May 1.PMID: 19411614 [PubMed - indexed for MEDLINE]Related articlesFree article

The relationship between sural nerve morphometric findings and measures of peripheral nerve function in mild diabetic neuropathy.

Veves A, Malik RA, Lye RH, Masson EA, Sharma AK, Schady W, Boulton AJ.

Diabet Med. 1991 Dec;8(10):917-21.PMID: 1838042 [PubMed - indexed for MEDLINE]Related articles

The electrophysiological findings of subclinical neuropathy in patients with recently diagnosed type 1 diabetes mellitus.

Karsidag S, Morali S, Sargin M, Salman S, Karsidag K, Us O.

Diabetes Res Clin Pract. 2005 Mar;67(3):211-9.PMID: 15713353 [PubMed - indexed for MEDLINE]Related articles

Elevated von Willebrand factor antigen predicts deterioration in diabetic peripheral nerve function.

Plater ME, Ford I, Dent MT, Preston FE, Ward JD.

Diabetologia. 1996 Mar;39(3):336-43.PMID: 8721780 [PubMed - indexed for MEDLINE]Related articles

Glycemic control is related to the electrophysiologic severity of diabetic peripheral sensorimotor polyneuropathy.

Tkac I, Bril V.

Diabetes Care. 1998 Oct;21(10):1749-52.PMID: 9773742 [PubMed - indexed for MEDLINE]Related articlesFree article

Superficial radial sensory nerve potentials in immune-mediated and diabetic neuropathies.

Tamura N, Kuwabara S, Misawa S, Mori M, Nakata M, Hattori T.

Clin Neurophysiol. 2005 Oct;116(10):2330-3.PMID: 16122982 [PubMed - indexed for MEDLINE]Related articles